Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A cardiologist shares insights on the findings.

South Korea offers two live zoster vaccines — SkyZoster was approved in 2017 and Zostavax in 2009. The US allowed Zostavax until 2020.. Researchers found that its effectiveness waned over time ...

The study is different in a major way. Previous research has shown a link between the shingles vaccine and dementia — for example, a 2024 study by the University of Oxford found that the newer ...

Shingles vaccine may cut heart disease risk, new study finds 03:48. Getting a shingles vaccine may help with more than the viral infection that causes painful rashes — new research shows it can ...

A novel approach in vaccine research offers hope for overcoming challenges in developing an effective Hepatitis C vaccine, targeting viral diversity and immune evasion.